Pennsylvania Appeals Court Affirms $76.66M Risperdal Gynecomastia Verdict
PHILADELPHIA — The Pennsylvania Superior Court on Nov. 26 affirmed a $76.66 million compensatory verdict in a Risperdal gynecomastia case, in part because defendants Janssen Pharmaceuticals Inc. allegedly concealed a study...To view the full article, register now.
Already a subscriber? Click here to view full article